| Literature DB >> 29874833 |
Alessandra La Gioia1, Emily Porter2, Ilja Merunka3, Atif Shahzad4, Saqib Salahuddin5, Marggie Jones6, Martin O'Halloran7.
Abstract
Electromagnetic (EM) medical technologies are rapidly expanding worldwide for both diagnostics and therapeutics. As these technologies are low-cost and minimally invasive, they have been the focus of significant research efforts in recent years. Such technologies are often based on the assumption that there is a contrast in the dielectric properties of different tissue types or that the properties of particular tissues fall within a defined range. Thus, accurate knowledge of the dielectric properties of biological tissues is fundamental to EM medical technologies. Over the past decades, numerous studies were conducted to expand the dielectric repository of biological tissues. However, dielectric data is not yet available for every tissue type and at every temperature and frequency. For this reason, dielectric measurements may be performed by researchers who are not specialists in the acquisition of tissue dielectric properties. To this end, this paper reviews the tissue dielectric measurement process performed with an open-ended coaxial probe. Given the high number of factors, including equipment- and tissue-related confounders, that can increase the measurement uncertainty or introduce errors into the tissue dielectric data, this work discusses each step of the coaxial probe measurement procedure, highlighting common practices, challenges, and techniques for controlling and compensating for confounders.Entities:
Keywords: biological tissues; dielectric measurements; equipment-related confounders; open-ended coaxial probe; tissue-related confounders
Year: 2018 PMID: 29874833 PMCID: PMC6023382 DOI: 10.3390/diagnostics8020040
Source DB: PubMed Journal: Diagnostics (Basel) ISSN: 2075-4418
Figure 1Open-ended coaxial probe technique: (a) Schematised measurement set-up, including the Vector Network Analyser (on the right), the cable connecting one port of the VNA to the coaxial probe, the probe bracket, and the liquid sample being measured; (b) top and side cross-sections of the coaxial probe, with electric field orientation indicated.
Use of the commercial probe in recent works. Studies involving breast tissues are shaded in grey. The others involve liver tissues, apart from the porcine skin study in Karacolak et al. [116]. In the column “Relative permittivity range”, the extreme values in relative permittivity are reported from lower to higher frequencies.
| Recent Works | Probe | Frequency [GHz] | Tissue Type | Sample Size | Relative Permittivity Range | Conductivity Range [S/m] |
|---|---|---|---|---|---|---|
| Halter et al. (2009) [ | Slim form with 2.2 mm diameter (in vivo) | 0.1–8.5 | Ex vivo and in vivo | 5 mm thick | In vivo breast tissue: 95–45 | In vivo breast tissue: 0.1–10 |
| High temperature with 19 mm flange (ex vivo) | Breast tumour (human) | Ex vivo breast tissue: 50–35 | Ex vivo breast tissue: 0.1–8 | |||
| Karacolak et al. (2012) [ | High temperature with 19 mm flange | 0.3–3 | Ex vivo skin (porcine) | 45 × 45 × 4 mm3 | 50–36 | 0.4–2.2 |
| Lopresto et al. (2012) [ | Slim form with 2.2 mm diameter | 2.45 | Ex vivo liver tissue (bovine) | 20 × 20 × 50 mm3 | 44.98–26.11 (temperature incremented from 15 °C to 98.9 °C, then decremented to 39.6 °C) | 1.79–1.19 (temperature incremented from 15 °C to 98.9 °C, then decremented to 39.6 °C) |
| Sabouni et al. (2013) [ | Performance with 9.5 mm diameter | 0.5–20 | Ex vivo breast tissue (human) | N/A | Breast tissue: 63–35 | Breast tissue: 0.2–32 |
| Fibroglandular breast tissue: 40–20 | Fibroglandular breast tissue: 0.2–16.3 | |||||
| Abdilla et al. (2013) [ | Slim form with 2.2 mm diameter | 0.5–50 | Ex vivo muscle and liver (bovine, porcine) | 60 × 60 × 40 mm3 | Muscle tissue: 58–18 | N/A(Loss factor for muscle/liver tissue: 32–10) |
| Sugitani et al. (2014) [ | Slim form with 2.2 mm diameter | 0.5–20 | Ex vivo breast tumour (human) | 50–300 mm diameter | Breast tumour tissue: 65–22 | Breast tumour tissue: 0.1–25 |
| Breast fibroglandular tissue: 40–18 | Breast fibroglandular tissue: 0.1–12 | |||||
| Breast fat tissue: 12–6 | Breast fat tissue: 0.1–3 | |||||
| Peyman et al. (2015) [ | Slim form with 2.2 mm diameter | 0.1–5 | Ex vivo liver tissue (human) | 20 mm thick | Liver normal tissue: 68–43 | Liver normal/tumour tissue: 0.7–5 |
| Martellosio et al. (2017) [ | Slim form with 2.2 mm diameter | 0.5–50 | Ex vivo breast tumour (human) | 6 mm thick volume between 700 mm3 and 1500 mm3 | Breast normal tissue: 64–3 | N/A |
The standard calibration process: Common errors or confounders that occur for each step in the calibration process, along with the possible correction or compensation techniques. The open circuit, short circuit, and a liquid load material are shown as the three calibration standards.
| Calibration Steps | Error or Confounder | Action for Correction or Compensation |
|---|---|---|
|
|
Environmental parameter change [ Probe contamination [ Imperfect connection [ Cable movement [ |
Control environmental parameters [ Inspect and clean probe [ Check connections [ Fixing cable position (if not phase-stable) [ |
|
|
Particles on probe tip [ |
Cleaning probe [ Checking the Smith Chart [ |
|
|
Poor probe-short block contact [ |
Cleaning short block and probe [ Reposition or re-contact short block with probe [ Checking the Smith chart [ |
|
|
Accuracy of liquid model [ Liquid temperature [ Air bubbles [ Liquid contamination [ Probe position in liquid [ |
Deionised water model has best accuracy [ Monitor or control temperature [ Re-immerse probe in liquid [ Limit exposure to air [ Place probe distant from beaker sides [ |
Reference liquid properties, available models, and storage and handling procedures (where f = frequency, T = temperature).
| Liquid | Models | Storage and Handling |
|---|---|---|
| Debye model [ f = 0.1–5 GHz T = [10 °C, 50 °C], 5 °C increments | Inflammable and acute inhalation toxicity. | |
| Cole-Cole model [ f = 0.01–70 GHz T = [10 °C, 40 °C], 10 °C increments | Rapid evaporation may occur and should be avoided. | |
| Cole-Davidson model [ f = 0.1–5 GHz T = [10 °C, 50 °C], 5 °C increments | Inflammable and acute inhalation toxicity. | |
| Debye-Γ model [ f = 0.1–5 GHz T = [10 °C, 5 0°C], 5°C increments | Inflammable and acute inhalation toxicity. | |
| Double Debye model [ f = 0.1–5 GHz T = [10°C, 40°C], 5 °C increments | Inflammable and acute inhalation toxicity. | |
| Cole-Cole model [ Concentrations = [0.001 mol/l, 5 mol/l] f = 0.13–20 GHz T = [5 °C, 35 °C] (any intermediate T) | Storage in sealed containers. | |
| Cole-Davidson model [ Concentrations = [0.001 mol/l, 1 mol/l] f = 0.1–40 GHz T = 17 temperatures in the interval [10 °C, 60 °C]: 10 °C, 20 °C, increments of 2 °C in [24 °C, 50 °C], and 60 °C. | ||
| Cole-Davidson model [ f = 0.2–89 GHz T = [10 °C, 25 °C], 5 °C increments T = [25 °C, 65 °C], 10 °C increments | Toxic through inhalation, oral, or skin exposure. | |
| Debye model [ f = 1.1–57 GHz T = [−4.1 °C, 60 °C] (any intermediate T) | Storage in sealed containers. | |
| Debye model [ f = 0.1–5 GHz T = [10 °C, 50 °C], 5 °C increments f = 0.001–40 GHz T = 25 °C | DMSO is exceptionally hygroscopic and needs to be measured as soon as the container is opened [ | |
| Static permittivity (since acetone has very high relaxation frequency) [ f = 0.1–5 GHz T = [10 °C, 50 °C], 5 °C increments | Acetone boiling point is at 56 °C [ | |
| Budo model/confined rotator models [ f = 50–310 GHz T = 20 °C | Special handling is required, since it is a powerful liquid able to soften some plastics [ |
Figure 2Flow chart of the common steps to minimise tissue-related errors in in vivo and ex vivo measurements.
Figure 3Diagram of sample composition by tissue type (fat—orange, gland—blue). A side view of the sample is shown, with slices marked. The dielectric probe measurement location is denoted with a black oval on the top of Slice 1.
Example calculations of total uncertainty in dielectric data resulting from tissue-related confounders under different measurement scenarios: Uncertainty due to time from excision (μTFE), due to temperature (μT), and due to age (μA). μ is the total uncertainty added to dielectric data, calculated as combined standard uncertainty. Uncertainty data is for the relative permittivity of mouse liver at 900 MHz, obtained from the literature. Note that 0.91% is 0.13%/°C ∙ 7°C.
| Case Scenarios | μT | μTFE | μA | μ |
|---|---|---|---|---|
| Known TFE, | 0.91% | N/A | N/A | 0.91% |
| Known T, | N/A | 25% | N/A | 25% |
| Known T, | N/A | N/A | 15% | 15% |
| Known T, | N/A | 25% | 15% | 29.15% |
| Known TFE, | 0.91% | N/A | 15% | 15.02% |
| Unknown TFE (within 3.5 h), | 0.91% | 25% | 15% | 29.17% |